Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (201-210 of 415) with videos related to

Pageof 42
Sort By:
Antimicrobial Agents and Chemotherapy|September 9, 2010
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteersMichael Neely, Laurent Decosterd, Aurélie Fayet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2008
Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroonCharles Kouanfack, Christian Laurent, Gilles Peytavin, et al.
Open Forum Infectious Diseases|February 19, 2021
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort StudyJose R Castillo-Mancilla, Matthias Cavassini, Marie Paule Schneider, et al.
Journal of the International AIDS Society|July 19, 2022
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to actionMartina Penazzato, Shahin Lockman, Angela Colbers, et al.
Revue Medicale Suisse|November 18, 2020
[Buyers' club : an alternative for access to treatment ?]Valentine Borcic, Alexandra Calmy, Samia Hurst, et al.
Open Forum Infectious Diseases|March 4, 2015
Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroonVanessa Christinet, Eric Comte, Laura Ciaffi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study GroupAntoine Benard, Ard van Sighem, Audrey Taieb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapyJean-Philippe Zuber, Alexandra Calmy, John M Evison, et al.
Antiviral Therapy|March 31, 2011
Successful efavirenz dose reduction guided by therapeutic drug monitoringAurélie Fayet Mello, Thierry Buclin, Laurent A Decosterd, et al.
Antiviral Therapy|May 4, 2005
Field assessment of generic antiretroviral drugs: a prospective cohort study in CameroonAnke Bourgeois, Christian Laurent, Rose Mougnutou, et al.
Pageof 42

Showing results (201-210 of 415) with videos related to

Sort By:
Pageof 42
Antimicrobial Agents and Chemotherapy|September 9, 2010
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteersMichael Neely, Laurent Decosterd, Aurélie Fayet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2008
Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroonCharles Kouanfack, Christian Laurent, Gilles Peytavin, et al.
Open Forum Infectious Diseases|February 19, 2021
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort StudyJose R Castillo-Mancilla, Matthias Cavassini, Marie Paule Schneider, et al.
Journal of the International AIDS Society|July 19, 2022
Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to actionMartina Penazzato, Shahin Lockman, Angela Colbers, et al.
Revue Medicale Suisse|November 18, 2020
[Buyers' club : an alternative for access to treatment ?]Valentine Borcic, Alexandra Calmy, Samia Hurst, et al.
Open Forum Infectious Diseases|March 4, 2015
Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroonVanessa Christinet, Eric Comte, Laura Ciaffi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study GroupAntoine Benard, Ard van Sighem, Audrey Taieb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapyJean-Philippe Zuber, Alexandra Calmy, John M Evison, et al.
Antiviral Therapy|March 31, 2011
Successful efavirenz dose reduction guided by therapeutic drug monitoringAurélie Fayet Mello, Thierry Buclin, Laurent A Decosterd, et al.
Antiviral Therapy|May 4, 2005
Field assessment of generic antiretroviral drugs: a prospective cohort study in CameroonAnke Bourgeois, Christian Laurent, Rose Mougnutou, et al.
Pageof 42